nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—AKR1C1—lung cancer	0.404	0.782	CbGaD
Salicylic acid—SLCO2B1—Erlotinib—lung cancer	0.0426	0.121	CbGbCtD
Salicylic acid—PTGS2—lung cancer	0.0411	0.0796	CbGaD
Salicylic acid—ALB—lung cancer	0.0366	0.0709	CbGaD
Salicylic acid—ABCB1—lung cancer	0.035	0.0677	CbGaD
Salicylic acid—SLC16A1—Methotrexate—lung cancer	0.0323	0.0917	CbGbCtD
Salicylic acid—SLC22A7—Docetaxel—lung cancer	0.022	0.0624	CbGbCtD
Salicylic acid—ALB—Gefitinib—lung cancer	0.0204	0.0578	CbGbCtD
Salicylic acid—SLC22A11—Methotrexate—lung cancer	0.0167	0.0473	CbGbCtD
Salicylic acid—SLC22A7—Methotrexate—lung cancer	0.0159	0.0451	CbGbCtD
Salicylic acid—PTGS2—Cisplatin—lung cancer	0.0141	0.0399	CbGbCtD
Salicylic acid—PTGS2—Etoposide—lung cancer	0.0138	0.0392	CbGbCtD
Salicylic acid—ALB—Erlotinib—lung cancer	0.0121	0.0342	CbGbCtD
Salicylic acid—PTGS1—Etoposide—lung cancer	0.0117	0.0331	CbGbCtD
Salicylic acid—ABCB1—Topotecan—lung cancer	0.0117	0.033	CbGbCtD
Salicylic acid—CYP2C9—Gefitinib—lung cancer	0.011	0.0311	CbGbCtD
Salicylic acid—ALB—Irinotecan—lung cancer	0.0109	0.0308	CbGbCtD
Salicylic acid—ABCB1—Gefitinib—lung cancer	0.0107	0.0302	CbGbCtD
Salicylic acid—CYP2C9—Teniposide—lung cancer	0.0107	0.0302	CbGbCtD
Salicylic acid—SLC22A8—Methotrexate—lung cancer	0.00971	0.0275	CbGbCtD
Salicylic acid—ABCB1—Vinorelbine—lung cancer	0.00822	0.0233	CbGbCtD
Salicylic acid—SLC22A6—Methotrexate—lung cancer	0.00676	0.0192	CbGbCtD
Salicylic acid—ABCB1—Crizotinib—lung cancer	0.00654	0.0185	CbGbCtD
Salicylic acid—ABCB1—Gemcitabine—lung cancer	0.00639	0.0181	CbGbCtD
Salicylic acid—ABCB1—Erlotinib—lung cancer	0.00631	0.0179	CbGbCtD
Salicylic acid—CYP2C9—Paclitaxel—lung cancer	0.00595	0.0169	CbGbCtD
Salicylic acid—ABCB1—Paclitaxel—lung cancer	0.00577	0.0164	CbGbCtD
Salicylic acid—ALB—Methotrexate—lung cancer	0.00576	0.0163	CbGbCtD
Salicylic acid—ABCB1—Irinotecan—lung cancer	0.00569	0.0161	CbGbCtD
Salicylic acid—ABCB1—Vinblastine—lung cancer	0.00506	0.0143	CbGbCtD
Salicylic acid—CYP2C9—Cisplatin—lung cancer	0.00478	0.0136	CbGbCtD
Salicylic acid—ABCB1—Cisplatin—lung cancer	0.00464	0.0132	CbGbCtD
Salicylic acid—ABCB1—Etoposide—lung cancer	0.00456	0.0129	CbGbCtD
Salicylic acid—ABCB1—Docetaxel—lung cancer	0.00417	0.0118	CbGbCtD
Salicylic acid—ABCB1—Doxorubicin—lung cancer	0.00311	0.00882	CbGbCtD
Salicylic acid—ABCB1—Methotrexate—lung cancer	0.00301	0.00854	CbGbCtD
Salicylic acid—Mefenamic acid—AKR1C1—lung cancer	0.000847	0.239	CrCbGaD
Salicylic acid—Acetylsalicylic acid—AKR1C1—lung cancer	0.000826	0.233	CrCbGaD
Salicylic acid—Acetylsalicylic acid—TP53—lung cancer	0.00043	0.121	CrCbGaD
Salicylic acid—Diarrhoea—Pemetrexed—lung cancer	0.000254	0.00379	CcSEcCtD
Salicylic acid—Diarrhoea—Gefitinib—lung cancer	0.000253	0.00376	CcSEcCtD
Salicylic acid—Feeling abnormal—Teniposide—lung cancer	0.000248	0.00369	CcSEcCtD
Salicylic acid—Deafness—Docetaxel—lung cancer	0.000247	0.00368	CcSEcCtD
Salicylic acid—Dizziness—Pemetrexed—lung cancer	0.000246	0.00366	CcSEcCtD
Salicylic acid—Nausea—Crizotinib—lung cancer	0.000242	0.0036	CcSEcCtD
Salicylic acid—Abdominal discomfort—Cisplatin—lung cancer	0.000241	0.00359	CcSEcCtD
Salicylic acid—Urticaria—Teniposide—lung cancer	0.000239	0.00356	CcSEcCtD
Salicylic acid—Abdominal pain upper—Paclitaxel—lung cancer	0.000239	0.00355	CcSEcCtD
Salicylic acid—Vomiting—Pemetrexed—lung cancer	0.000236	0.00352	CcSEcCtD
Salicylic acid—Stinging—Doxorubicin—lung cancer	0.000235	0.0035	CcSEcCtD
Salicylic acid—Vomiting—Gefitinib—lung cancer	0.000235	0.0035	CcSEcCtD
Salicylic acid—Rash—Pemetrexed—lung cancer	0.000234	0.00349	CcSEcCtD
Salicylic acid—Dermatitis—Pemetrexed—lung cancer	0.000234	0.00349	CcSEcCtD
Salicylic acid—Erythema—Vinorelbine—lung cancer	0.000234	0.00348	CcSEcCtD
Salicylic acid—Rash—Gefitinib—lung cancer	0.000233	0.00347	CcSEcCtD
Salicylic acid—Dermatitis—Gefitinib—lung cancer	0.000233	0.00346	CcSEcCtD
Salicylic acid—Lethargy—Docetaxel—lung cancer	0.000226	0.00336	CcSEcCtD
Salicylic acid—Oedema—Erlotinib—lung cancer	0.000221	0.00329	CcSEcCtD
Salicylic acid—Nausea—Pemetrexed—lung cancer	0.000221	0.00329	CcSEcCtD
Salicylic acid—Nausea—Gefitinib—lung cancer	0.000219	0.00327	CcSEcCtD
Salicylic acid—Anorexia—Vinblastine—lung cancer	0.000219	0.00326	CcSEcCtD
Salicylic acid—Pruritus—Teniposide—lung cancer	0.000213	0.00317	CcSEcCtD
Salicylic acid—Anorexia—Topotecan—lung cancer	0.000213	0.00317	CcSEcCtD
Salicylic acid—Anorexia—Erlotinib—lung cancer	0.00021	0.00313	CcSEcCtD
Salicylic acid—Skin exfoliation—Methotrexate—lung cancer	0.00021	0.00312	CcSEcCtD
Salicylic acid—Diarrhoea—Teniposide—lung cancer	0.000206	0.00307	CcSEcCtD
Salicylic acid—Weight increased—Paclitaxel—lung cancer	0.000205	0.00306	CcSEcCtD
Salicylic acid—Erythema multiforme—Gemcitabine—lung cancer	0.000204	0.00304	CcSEcCtD
Salicylic acid—Abdominal pain upper—Docetaxel—lung cancer	0.000202	0.00301	CcSEcCtD
Salicylic acid—Decreased appetite—Vinblastine—lung cancer	0.0002	0.00297	CcSEcCtD
Salicylic acid—Ecchymosis—Methotrexate—lung cancer	0.000199	0.00296	CcSEcCtD
Salicylic acid—Constipation—Vinblastine—lung cancer	0.000196	0.00292	CcSEcCtD
Salicylic acid—Pain—Vinblastine—lung cancer	0.000196	0.00292	CcSEcCtD
Salicylic acid—Dyspepsia—Topotecan—lung cancer	0.000196	0.00292	CcSEcCtD
Salicylic acid—Dyspepsia—Erlotinib—lung cancer	0.000194	0.00289	CcSEcCtD
Salicylic acid—Decreased appetite—Topotecan—lung cancer	0.000194	0.00289	CcSEcCtD
Salicylic acid—Salicylate-sodium—PTGS2—lung cancer	0.000193	0.0545	CrCbGaD
Salicylic acid—Decreased appetite—Erlotinib—lung cancer	0.000192	0.00286	CcSEcCtD
Salicylic acid—Vomiting—Teniposide—lung cancer	0.000191	0.00285	CcSEcCtD
Salicylic acid—Constipation—Topotecan—lung cancer	0.000191	0.00284	CcSEcCtD
Salicylic acid—Pain—Topotecan—lung cancer	0.000191	0.00284	CcSEcCtD
Salicylic acid—Epistaxis—Paclitaxel—lung cancer	0.00019	0.00283	CcSEcCtD
Salicylic acid—Rash—Teniposide—lung cancer	0.00019	0.00283	CcSEcCtD
Salicylic acid—Dermatitis—Teniposide—lung cancer	0.00019	0.00282	CcSEcCtD
Salicylic acid—Feeling abnormal—Vinblastine—lung cancer	0.000189	0.00282	CcSEcCtD
Salicylic acid—Constipation—Erlotinib—lung cancer	0.000189	0.00281	CcSEcCtD
Salicylic acid—Pain—Erlotinib—lung cancer	0.000189	0.00281	CcSEcCtD
Salicylic acid—Headache—Teniposide—lung cancer	0.000189	0.00281	CcSEcCtD
Salicylic acid—Erythema—Gemcitabine—lung cancer	0.000188	0.0028	CcSEcCtD
Salicylic acid—Tinnitus—Cisplatin—lung cancer	0.000188	0.00279	CcSEcCtD
Salicylic acid—Feeling abnormal—Topotecan—lung cancer	0.000184	0.00274	CcSEcCtD
Salicylic acid—Anorexia—Vinorelbine—lung cancer	0.000182	0.00271	CcSEcCtD
Salicylic acid—Skin exfoliation—Doxorubicin—lung cancer	0.000182	0.00271	CcSEcCtD
Salicylic acid—Nausea—Teniposide—lung cancer	0.000179	0.00266	CcSEcCtD
Salicylic acid—Urticaria—Topotecan—lung cancer	0.000177	0.00264	CcSEcCtD
Salicylic acid—Erythema—Cisplatin—lung cancer	0.000175	0.00261	CcSEcCtD
Salicylic acid—Erythema multiforme—Etoposide—lung cancer	0.000174	0.00259	CcSEcCtD
Salicylic acid—Weight increased—Docetaxel—lung cancer	0.000174	0.00259	CcSEcCtD
Salicylic acid—Oesophagitis—Doxorubicin—lung cancer	0.000174	0.00259	CcSEcCtD
Salicylic acid—Ecchymosis—Doxorubicin—lung cancer	0.000172	0.00256	CcSEcCtD
Salicylic acid—Erythema multiforme—Paclitaxel—lung cancer	0.000171	0.00254	CcSEcCtD
Salicylic acid—Tinnitus—Paclitaxel—lung cancer	0.000168	0.00251	CcSEcCtD
Salicylic acid—Decreased appetite—Vinorelbine—lung cancer	0.000166	0.00247	CcSEcCtD
Salicylic acid—Constipation—Vinorelbine—lung cancer	0.000163	0.00243	CcSEcCtD
Salicylic acid—Pain—Vinorelbine—lung cancer	0.000163	0.00243	CcSEcCtD
Salicylic acid—Lethargy—Methotrexate—lung cancer	0.000163	0.00242	CcSEcCtD
Salicylic acid—Epistaxis—Docetaxel—lung cancer	0.000161	0.0024	CcSEcCtD
Salicylic acid—Confusional state—Irinotecan—lung cancer	0.000159	0.00236	CcSEcCtD
Salicylic acid—Pruritus—Topotecan—lung cancer	0.000158	0.00235	CcSEcCtD
Salicylic acid—Oedema—Irinotecan—lung cancer	0.000157	0.00234	CcSEcCtD
Salicylic acid—Erythema—Paclitaxel—lung cancer	0.000157	0.00234	CcSEcCtD
Salicylic acid—Feeling abnormal—Vinorelbine—lung cancer	0.000157	0.00234	CcSEcCtD
Salicylic acid—Diarrhoea—Vinblastine—lung cancer	0.000157	0.00234	CcSEcCtD
Salicylic acid—Dysgeusia—Etoposide—lung cancer	0.000157	0.00234	CcSEcCtD
Salicylic acid—Pruritus—Erlotinib—lung cancer	0.000156	0.00233	CcSEcCtD
Salicylic acid—Dysgeusia—Paclitaxel—lung cancer	0.000154	0.00229	CcSEcCtD
Salicylic acid—Oedema—Gemcitabine—lung cancer	0.000153	0.00228	CcSEcCtD
Salicylic acid—Hepatitis—Docetaxel—lung cancer	0.000153	0.00228	CcSEcCtD
Salicylic acid—Diarrhoea—Topotecan—lung cancer	0.000153	0.00227	CcSEcCtD
Salicylic acid—Dizziness—Vinblastine—lung cancer	0.000152	0.00226	CcSEcCtD
Salicylic acid—Urticaria—Vinorelbine—lung cancer	0.000152	0.00226	CcSEcCtD
Salicylic acid—Diarrhoea—Erlotinib—lung cancer	0.000151	0.00225	CcSEcCtD
Salicylic acid—Anorexia—Irinotecan—lung cancer	0.00015	0.00223	CcSEcCtD
Salicylic acid—Dizziness—Topotecan—lung cancer	0.000148	0.0022	CcSEcCtD
Salicylic acid—Anorexia—Gemcitabine—lung cancer	0.000146	0.00218	CcSEcCtD
Salicylic acid—Vomiting—Vinblastine—lung cancer	0.000146	0.00217	CcSEcCtD
Salicylic acid—Dizziness—Erlotinib—lung cancer	0.000146	0.00217	CcSEcCtD
Salicylic acid—Erythema multiforme—Docetaxel—lung cancer	0.000145	0.00216	CcSEcCtD
Salicylic acid—Headache—Vinblastine—lung cancer	0.000144	0.00214	CcSEcCtD
Salicylic acid—Oedema—Cisplatin—lung cancer	0.000143	0.00213	CcSEcCtD
Salicylic acid—Vomiting—Topotecan—lung cancer	0.000142	0.00211	CcSEcCtD
Salicylic acid—Lethargy—Doxorubicin—lung cancer	0.000141	0.0021	CcSEcCtD
Salicylic acid—Rash—Topotecan—lung cancer	0.000141	0.00209	CcSEcCtD
Salicylic acid—Dermatitis—Topotecan—lung cancer	0.000141	0.00209	CcSEcCtD
Salicylic acid—Vomiting—Erlotinib—lung cancer	0.00014	0.00209	CcSEcCtD
Salicylic acid—Somnolence—Irinotecan—lung cancer	0.00014	0.00208	CcSEcCtD
Salicylic acid—Headache—Topotecan—lung cancer	0.00014	0.00208	CcSEcCtD
Salicylic acid—Rash—Erlotinib—lung cancer	0.000139	0.00207	CcSEcCtD
Salicylic acid—Dermatitis—Erlotinib—lung cancer	0.000139	0.00207	CcSEcCtD
Salicylic acid—Dyspepsia—Irinotecan—lung cancer	0.000139	0.00206	CcSEcCtD
Salicylic acid—Headache—Erlotinib—lung cancer	0.000138	0.00206	CcSEcCtD
Salicylic acid—Asthma—Methotrexate—lung cancer	0.000138	0.00205	CcSEcCtD
Salicylic acid—Decreased appetite—Irinotecan—lung cancer	0.000137	0.00204	CcSEcCtD
Salicylic acid—Nausea—Vinblastine—lung cancer	0.000136	0.00203	CcSEcCtD
Salicylic acid—Somnolence—Gemcitabine—lung cancer	0.000136	0.00203	CcSEcCtD
Salicylic acid—Anorexia—Cisplatin—lung cancer	0.000136	0.00203	CcSEcCtD
Salicylic acid—Pruritus—Vinorelbine—lung cancer	0.000135	0.00201	CcSEcCtD
Salicylic acid—Pain—Irinotecan—lung cancer	0.000135	0.002	CcSEcCtD
Salicylic acid—Constipation—Irinotecan—lung cancer	0.000135	0.002	CcSEcCtD
Salicylic acid—Erythema—Docetaxel—lung cancer	0.000133	0.00199	CcSEcCtD
Salicylic acid—Decreased appetite—Gemcitabine—lung cancer	0.000133	0.00198	CcSEcCtD
Salicylic acid—Nausea—Topotecan—lung cancer	0.000133	0.00197	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS2—lung cancer	0.000132	0.0373	CrCbGaD
Salicylic acid—Abdominal discomfort—Methotrexate—lung cancer	0.000132	0.00197	CcSEcCtD
Salicylic acid—Confusional state—Etoposide—lung cancer	0.000132	0.00197	CcSEcCtD
Salicylic acid—Pain—Gemcitabine—lung cancer	0.000131	0.00195	CcSEcCtD
Salicylic acid—Constipation—Gemcitabine—lung cancer	0.000131	0.00195	CcSEcCtD
Salicylic acid—Nausea—Erlotinib—lung cancer	0.000131	0.00195	CcSEcCtD
Salicylic acid—Diarrhoea—Vinorelbine—lung cancer	0.000131	0.00194	CcSEcCtD
Salicylic acid—Dysgeusia—Docetaxel—lung cancer	0.000131	0.00194	CcSEcCtD
Salicylic acid—Feeling abnormal—Irinotecan—lung cancer	0.00013	0.00193	CcSEcCtD
Salicylic acid—Confusional state—Paclitaxel—lung cancer	0.000129	0.00193	CcSEcCtD
Salicylic acid—Oedema—Paclitaxel—lung cancer	0.000128	0.00191	CcSEcCtD
Salicylic acid—Feeling abnormal—Gemcitabine—lung cancer	0.000126	0.00188	CcSEcCtD
Salicylic acid—Dizziness—Vinorelbine—lung cancer	0.000126	0.00188	CcSEcCtD
Salicylic acid—Abdominal pain upper—Doxorubicin—lung cancer	0.000126	0.00188	CcSEcCtD
Salicylic acid—Anorexia—Etoposide—lung cancer	0.000125	0.00186	CcSEcCtD
Salicylic acid—Diflunisal—PTGS2—lung cancer	0.000124	0.0351	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS2—lung cancer	0.000124	0.0351	CrCbGaD
Salicylic acid—Decreased appetite—Cisplatin—lung cancer	0.000124	0.00185	CcSEcCtD
Salicylic acid—Drowsiness—Methotrexate—lung cancer	0.000123	0.00183	CcSEcCtD
Salicylic acid—Anorexia—Paclitaxel—lung cancer	0.000122	0.00182	CcSEcCtD
Salicylic acid—Pain—Cisplatin—lung cancer	0.000122	0.00182	CcSEcCtD
Salicylic acid—Vomiting—Vinorelbine—lung cancer	0.000121	0.00181	CcSEcCtD
Salicylic acid—Rash—Vinorelbine—lung cancer	0.00012	0.00179	CcSEcCtD
Salicylic acid—Dermatitis—Vinorelbine—lung cancer	0.00012	0.00179	CcSEcCtD
Salicylic acid—Headache—Vinorelbine—lung cancer	0.00012	0.00178	CcSEcCtD
Salicylic acid—Asthma—Doxorubicin—lung cancer	0.000119	0.00178	CcSEcCtD
Salicylic acid—Magnesium salicylate—ALB—lung cancer	0.000118	0.0333	CrCbGaD
Salicylic acid—Feeling abnormal—Cisplatin—lung cancer	0.000118	0.00175	CcSEcCtD
Salicylic acid—Somnolence—Etoposide—lung cancer	0.000116	0.00173	CcSEcCtD
Salicylic acid—Epistaxis—Methotrexate—lung cancer	0.000116	0.00173	CcSEcCtD
Salicylic acid—Somnolence—Paclitaxel—lung cancer	0.000114	0.0017	CcSEcCtD
Salicylic acid—Decreased appetite—Etoposide—lung cancer	0.000114	0.00169	CcSEcCtD
Salicylic acid—Nausea—Vinorelbine—lung cancer	0.000113	0.00169	CcSEcCtD
Salicylic acid—Dyspepsia—Paclitaxel—lung cancer	0.000113	0.00168	CcSEcCtD
Salicylic acid—Salsalate—PTGS2—lung cancer	0.000113	0.0318	CrCbGaD
Salicylic acid—Constipation—Etoposide—lung cancer	0.000112	0.00167	CcSEcCtD
Salicylic acid—Pain—Etoposide—lung cancer	0.000112	0.00167	CcSEcCtD
Salicylic acid—Decreased appetite—Paclitaxel—lung cancer	0.000112	0.00166	CcSEcCtD
Salicylic acid—Meclofenamic acid—PTGS2—lung cancer	0.000111	0.0313	CrCbGaD
Salicylic acid—Diflunisal—ALB—lung cancer	0.000111	0.0313	CrCbGaD
Salicylic acid—Hepatitis—Methotrexate—lung cancer	0.00011	0.00164	CcSEcCtD
Salicylic acid—Pain—Paclitaxel—lung cancer	0.00011	0.00163	CcSEcCtD
Salicylic acid—Constipation—Paclitaxel—lung cancer	0.00011	0.00163	CcSEcCtD
Salicylic acid—Confusional state—Docetaxel—lung cancer	0.00011	0.00163	CcSEcCtD
Salicylic acid—Oedema—Docetaxel—lung cancer	0.000109	0.00162	CcSEcCtD
Salicylic acid—Weight increased—Doxorubicin—lung cancer	0.000109	0.00162	CcSEcCtD
Salicylic acid—Pruritus—Gemcitabine—lung cancer	0.000108	0.00162	CcSEcCtD
Salicylic acid—Feeling abnormal—Etoposide—lung cancer	0.000108	0.00161	CcSEcCtD
Salicylic acid—Diarrhoea—Irinotecan—lung cancer	0.000108	0.0016	CcSEcCtD
Salicylic acid—Drowsiness—Doxorubicin—lung cancer	0.000106	0.00159	CcSEcCtD
Salicylic acid—Feeling abnormal—Paclitaxel—lung cancer	0.000106	0.00158	CcSEcCtD
Salicylic acid—Diarrhoea—Gemcitabine—lung cancer	0.000105	0.00156	CcSEcCtD
Salicylic acid—Erythema multiforme—Methotrexate—lung cancer	0.000104	0.00155	CcSEcCtD
Salicylic acid—Dizziness—Irinotecan—lung cancer	0.000104	0.00155	CcSEcCtD
Salicylic acid—Urticaria—Etoposide—lung cancer	0.000104	0.00155	CcSEcCtD
Salicylic acid—Anorexia—Docetaxel—lung cancer	0.000104	0.00154	CcSEcCtD
Salicylic acid—Tinnitus—Methotrexate—lung cancer	0.000103	0.00153	CcSEcCtD
Salicylic acid—Urticaria—Paclitaxel—lung cancer	0.000102	0.00152	CcSEcCtD
Salicylic acid—Epistaxis—Doxorubicin—lung cancer	0.0001	0.0015	CcSEcCtD
Salicylic acid—Vomiting—Irinotecan—lung cancer	0.0001	0.00149	CcSEcCtD
Salicylic acid—Rash—Irinotecan—lung cancer	9.93e-05	0.00148	CcSEcCtD
Salicylic acid—Dermatitis—Irinotecan—lung cancer	9.92e-05	0.00148	CcSEcCtD
Salicylic acid—Headache—Irinotecan—lung cancer	9.86e-05	0.00147	CcSEcCtD
Salicylic acid—Diarrhoea—Cisplatin—lung cancer	9.78e-05	0.00146	CcSEcCtD
Salicylic acid—Mesalazine—PTGS2—lung cancer	9.77e-05	0.0276	CrCbGaD
Salicylic acid—Vomiting—Gemcitabine—lung cancer	9.75e-05	0.00145	CcSEcCtD
Salicylic acid—Somnolence—Docetaxel—lung cancer	9.67e-05	0.00144	CcSEcCtD
Salicylic acid—Rash—Gemcitabine—lung cancer	9.67e-05	0.00144	CcSEcCtD
Salicylic acid—Dermatitis—Gemcitabine—lung cancer	9.66e-05	0.00144	CcSEcCtD
Salicylic acid—Erythema—Methotrexate—lung cancer	9.61e-05	0.00143	CcSEcCtD
Salicylic acid—Headache—Gemcitabine—lung cancer	9.61e-05	0.00143	CcSEcCtD
Salicylic acid—Dyspepsia—Docetaxel—lung cancer	9.58e-05	0.00143	CcSEcCtD
Salicylic acid—Hepatitis—Doxorubicin—lung cancer	9.56e-05	0.00142	CcSEcCtD
Salicylic acid—Decreased appetite—Docetaxel—lung cancer	9.46e-05	0.00141	CcSEcCtD
Salicylic acid—Dysgeusia—Methotrexate—lung cancer	9.41e-05	0.0014	CcSEcCtD
Salicylic acid—Nausea—Irinotecan—lung cancer	9.35e-05	0.00139	CcSEcCtD
Salicylic acid—Pain—Docetaxel—lung cancer	9.31e-05	0.00139	CcSEcCtD
Salicylic acid—Constipation—Docetaxel—lung cancer	9.31e-05	0.00139	CcSEcCtD
Salicylic acid—Pruritus—Etoposide—lung cancer	9.26e-05	0.00138	CcSEcCtD
Salicylic acid—Nausea—Gemcitabine—lung cancer	9.11e-05	0.00136	CcSEcCtD
Salicylic acid—Vomiting—Cisplatin—lung cancer	9.09e-05	0.00135	CcSEcCtD
Salicylic acid—Pruritus—Paclitaxel—lung cancer	9.08e-05	0.00135	CcSEcCtD
Salicylic acid—Erythema multiforme—Doxorubicin—lung cancer	9.04e-05	0.00135	CcSEcCtD
Salicylic acid—Rash—Cisplatin—lung cancer	9.01e-05	0.00134	CcSEcCtD
Salicylic acid—Dermatitis—Cisplatin—lung cancer	9e-05	0.00134	CcSEcCtD
Salicylic acid—Feeling abnormal—Docetaxel—lung cancer	8.97e-05	0.00134	CcSEcCtD
Salicylic acid—Diarrhoea—Etoposide—lung cancer	8.96e-05	0.00133	CcSEcCtD
Salicylic acid—Tinnitus—Doxorubicin—lung cancer	8.91e-05	0.00133	CcSEcCtD
Salicylic acid—Diarrhoea—Paclitaxel—lung cancer	8.78e-05	0.00131	CcSEcCtD
Salicylic acid—Dizziness—Etoposide—lung cancer	8.66e-05	0.00129	CcSEcCtD
Salicylic acid—Mefenamic acid—PTGS2—lung cancer	8.63e-05	0.0243	CrCbGaD
Salicylic acid—Dizziness—Paclitaxel—lung cancer	8.49e-05	0.00126	CcSEcCtD
Salicylic acid—Nausea—Cisplatin—lung cancer	8.49e-05	0.00126	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS2—lung cancer	8.41e-05	0.0237	CrCbGaD
Salicylic acid—Vomiting—Etoposide—lung cancer	8.33e-05	0.00124	CcSEcCtD
Salicylic acid—Erythema—Doxorubicin—lung cancer	8.32e-05	0.00124	CcSEcCtD
Salicylic acid—Rash—Etoposide—lung cancer	8.26e-05	0.00123	CcSEcCtD
Salicylic acid—Dermatitis—Etoposide—lung cancer	8.25e-05	0.00123	CcSEcCtD
Salicylic acid—Headache—Etoposide—lung cancer	8.2e-05	0.00122	CcSEcCtD
Salicylic acid—Vomiting—Paclitaxel—lung cancer	8.16e-05	0.00122	CcSEcCtD
Salicylic acid—Dysgeusia—Doxorubicin—lung cancer	8.15e-05	0.00121	CcSEcCtD
Salicylic acid—Rash—Paclitaxel—lung cancer	8.09e-05	0.00121	CcSEcCtD
Salicylic acid—Dermatitis—Paclitaxel—lung cancer	8.09e-05	0.0012	CcSEcCtD
Salicylic acid—Headache—Paclitaxel—lung cancer	8.04e-05	0.0012	CcSEcCtD
Salicylic acid—Confusional state—Methotrexate—lung cancer	7.91e-05	0.00118	CcSEcCtD
Salicylic acid—Nausea—Etoposide—lung cancer	7.78e-05	0.00116	CcSEcCtD
Salicylic acid—Pruritus—Docetaxel—lung cancer	7.7e-05	0.00115	CcSEcCtD
Salicylic acid—Nausea—Paclitaxel—lung cancer	7.63e-05	0.00114	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ALB—lung cancer	7.49e-05	0.0211	CrCbGaD
Salicylic acid—Anorexia—Methotrexate—lung cancer	7.48e-05	0.00111	CcSEcCtD
Salicylic acid—Diarrhoea—Docetaxel—lung cancer	7.45e-05	0.00111	CcSEcCtD
Salicylic acid—Dizziness—Docetaxel—lung cancer	7.2e-05	0.00107	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ABCB1—lung cancer	7.15e-05	0.0202	CrCbGaD
Salicylic acid—Somnolence—Methotrexate—lung cancer	6.97e-05	0.00104	CcSEcCtD
Salicylic acid—Vomiting—Docetaxel—lung cancer	6.92e-05	0.00103	CcSEcCtD
Salicylic acid—Dyspepsia—Methotrexate—lung cancer	6.9e-05	0.00103	CcSEcCtD
Salicylic acid—Rash—Docetaxel—lung cancer	6.86e-05	0.00102	CcSEcCtD
Salicylic acid—Dermatitis—Docetaxel—lung cancer	6.85e-05	0.00102	CcSEcCtD
Salicylic acid—Confusional state—Doxorubicin—lung cancer	6.85e-05	0.00102	CcSEcCtD
Salicylic acid—Decreased appetite—Methotrexate—lung cancer	6.82e-05	0.00102	CcSEcCtD
Salicylic acid—Headache—Docetaxel—lung cancer	6.82e-05	0.00101	CcSEcCtD
Salicylic acid—Oedema—Doxorubicin—lung cancer	6.79e-05	0.00101	CcSEcCtD
Salicylic acid—Pain—Methotrexate—lung cancer	6.71e-05	0.000999	CcSEcCtD
Salicylic acid—Anorexia—Doxorubicin—lung cancer	6.47e-05	0.000964	CcSEcCtD
Salicylic acid—Nausea—Docetaxel—lung cancer	6.46e-05	0.000962	CcSEcCtD
Salicylic acid—Feeling abnormal—Methotrexate—lung cancer	6.46e-05	0.000962	CcSEcCtD
Salicylic acid—Urticaria—Methotrexate—lung cancer	6.23e-05	0.000928	CcSEcCtD
Salicylic acid—Somnolence—Doxorubicin—lung cancer	6.04e-05	0.000899	CcSEcCtD
Salicylic acid—Dyspepsia—Doxorubicin—lung cancer	5.98e-05	0.00089	CcSEcCtD
Salicylic acid—Decreased appetite—Doxorubicin—lung cancer	5.9e-05	0.000879	CcSEcCtD
Salicylic acid—Constipation—Doxorubicin—lung cancer	5.81e-05	0.000865	CcSEcCtD
Salicylic acid—Pain—Doxorubicin—lung cancer	5.81e-05	0.000865	CcSEcCtD
Salicylic acid—Feeling abnormal—Doxorubicin—lung cancer	5.6e-05	0.000833	CcSEcCtD
Salicylic acid—Pruritus—Methotrexate—lung cancer	5.55e-05	0.000826	CcSEcCtD
Salicylic acid—Urticaria—Doxorubicin—lung cancer	5.4e-05	0.000803	CcSEcCtD
Salicylic acid—Diarrhoea—Methotrexate—lung cancer	5.37e-05	0.000799	CcSEcCtD
Salicylic acid—Dizziness—Methotrexate—lung cancer	5.19e-05	0.000772	CcSEcCtD
Salicylic acid—Vomiting—Methotrexate—lung cancer	4.99e-05	0.000742	CcSEcCtD
Salicylic acid—Rash—Methotrexate—lung cancer	4.95e-05	0.000736	CcSEcCtD
Salicylic acid—Dermatitis—Methotrexate—lung cancer	4.94e-05	0.000736	CcSEcCtD
Salicylic acid—Headache—Methotrexate—lung cancer	4.91e-05	0.000732	CcSEcCtD
Salicylic acid—Pruritus—Doxorubicin—lung cancer	4.8e-05	0.000715	CcSEcCtD
Salicylic acid—Nausea—Methotrexate—lung cancer	4.66e-05	0.000694	CcSEcCtD
Salicylic acid—Diarrhoea—Doxorubicin—lung cancer	4.65e-05	0.000692	CcSEcCtD
Salicylic acid—Dizziness—Doxorubicin—lung cancer	4.49e-05	0.000669	CcSEcCtD
Salicylic acid—Vomiting—Doxorubicin—lung cancer	4.32e-05	0.000643	CcSEcCtD
Salicylic acid—Rash—Doxorubicin—lung cancer	4.28e-05	0.000638	CcSEcCtD
Salicylic acid—Dermatitis—Doxorubicin—lung cancer	4.28e-05	0.000637	CcSEcCtD
Salicylic acid—Headache—Doxorubicin—lung cancer	4.25e-05	0.000633	CcSEcCtD
Salicylic acid—Nausea—Doxorubicin—lung cancer	4.03e-05	0.000601	CcSEcCtD
Salicylic acid—ALB—Metabolism—ALDOA—lung cancer	6.26e-06	0.000105	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.24e-06	0.000104	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTA2—lung cancer	6.22e-06	0.000104	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	6.22e-06	0.000104	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.15e-06	0.000103	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AKR1C1—lung cancer	6.15e-06	0.000103	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CREBBP—lung cancer	6.08e-06	0.000102	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NCOA3—lung cancer	6.07e-06	0.000102	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTP1—lung cancer	6.07e-06	0.000102	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CB—lung cancer	6.04e-06	0.000101	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KRAS—lung cancer	6.01e-06	0.000101	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTA1—lung cancer	6e-06	0.0001	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FOXO3—lung cancer	6e-06	0.0001	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—lung cancer	5.98e-06	0.0001	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—UGT1A1—lung cancer	5.97e-06	0.0001	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.97e-06	0.0001	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	5.94e-06	9.95e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCC3—lung cancer	5.93e-06	9.94e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ADCY1—lung cancer	5.91e-06	9.9e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCG2—lung cancer	5.91e-06	9.9e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CAT—lung cancer	5.9e-06	9.89e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.87e-06	9.83e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.85e-06	9.8e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP2E1—lung cancer	5.84e-06	9.78e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—HPGDS—lung cancer	5.79e-06	9.7e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ENO2—lung cancer	5.79e-06	9.7e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NQO1—lung cancer	5.77e-06	9.67e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CD—lung cancer	5.76e-06	9.65e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPP2R1B—lung cancer	5.76e-06	9.64e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GNG11—lung cancer	5.76e-06	9.64e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AKR1C1—lung cancer	5.75e-06	9.62e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ABCB1—lung cancer	5.74e-06	9.62e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.68e-06	9.52e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.66e-06	9.48e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.65e-06	9.47e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—TYMS—lung cancer	5.64e-06	9.44e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTT1—lung cancer	5.62e-06	9.41e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—UGT1A1—lung cancer	5.58e-06	9.34e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTM1—lung cancer	5.57e-06	9.34e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GCLC—lung cancer	5.55e-06	9.3e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2A6—lung cancer	5.55e-06	9.3e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.53e-06	9.27e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CA—lung cancer	5.52e-06	9.24e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALDOA—lung cancer	5.48e-06	9.18e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	5.45e-06	9.12e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—AKT1—lung cancer	5.39e-06	9.03e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GNG11—lung cancer	5.38e-06	9.01e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.35e-06	8.96e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—lung cancer	5.34e-06	8.94e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NCOA3—lung cancer	5.32e-06	8.91e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HES1—lung cancer	5.31e-06	8.9e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP1A1—lung cancer	5.28e-06	8.85e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ENO1—lung cancer	5.27e-06	8.82e-05	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	5.26e-06	8.81e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.25e-06	8.79e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ERCC2—lung cancer	5.24e-06	8.78e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTEN—lung cancer	5.22e-06	8.74e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—STK11—lung cancer	5.2e-06	8.72e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ADCY1—lung cancer	5.18e-06	8.67e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ABCG2—lung cancer	5.18e-06	8.67e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAF1—lung cancer	5.15e-06	8.62e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALDOA—lung cancer	5.12e-06	8.58e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HRAS—lung cancer	5.11e-06	8.55e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—HPGDS—lung cancer	5.08e-06	8.5e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ENO2—lung cancer	5.08e-06	8.5e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPP2R1B—lung cancer	5.04e-06	8.45e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CB—lung cancer	5.02e-06	8.41e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—EP300—lung cancer	4.97e-06	8.33e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NCOA3—lung cancer	4.97e-06	8.33e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERCC2—lung cancer	4.97e-06	8.32e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTT1—lung cancer	4.92e-06	8.25e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—lung cancer	4.89e-06	8.19e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.89e-06	8.18e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.88e-06	8.18e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2A6—lung cancer	4.87e-06	8.15e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GCLC—lung cancer	4.87e-06	8.15e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB3—lung cancer	4.86e-06	8.14e-05	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	4.85e-06	8.13e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ADCY1—lung cancer	4.84e-06	8.1e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCG2—lung cancer	4.84e-06	8.1e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTP1—lung cancer	4.81e-06	8.06e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.78e-06	8e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HPGDS—lung cancer	4.74e-06	7.94e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ENO2—lung cancer	4.74e-06	7.94e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2E1—lung cancer	4.72e-06	7.91e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.71e-06	7.89e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CAT—lung cancer	4.69e-06	7.85e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NQO1—lung cancer	4.67e-06	7.82e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.66e-06	7.8e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TERT—lung cancer	4.66e-06	7.8e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.65e-06	7.79e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ENO1—lung cancer	4.61e-06	7.73e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—lung cancer	4.61e-06	7.73e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.61e-06	7.72e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTT1—lung cancer	4.6e-06	7.7e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.57e-06	7.66e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ABCB1—lung cancer	4.56e-06	7.63e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GCLC—lung cancer	4.55e-06	7.62e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP2A6—lung cancer	4.55e-06	7.62e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—APOA1—lung cancer	4.53e-06	7.59e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.53e-06	7.59e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.53e-06	7.59e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FGFR1—lung cancer	4.52e-06	7.57e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AKT1—lung cancer	4.51e-06	7.55e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TYMS—lung cancer	4.48e-06	7.5e-05	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	4.45e-06	7.46e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HIF1A—lung cancer	4.45e-06	7.46e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTM1—lung cancer	4.42e-06	7.41e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.34e-06	7.27e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.32e-06	7.23e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ENO1—lung cancer	4.31e-06	7.22e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APOA1—lung cancer	4.3e-06	7.2e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.29e-06	7.19e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.24e-06	7.1e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—STK11—lung cancer	4.21e-06	7.05e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP1A1—lung cancer	4.19e-06	7.03e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ERCC2—lung cancer	4.16e-06	6.97e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—EP300—lung cancer	4.14e-06	6.93e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2E1—lung cancer	4.14e-06	6.93e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CG—lung cancer	4.14e-06	6.93e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NQO1—lung cancer	4.09e-06	6.85e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—SRC—lung cancer	4.03e-06	6.74e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.95e-06	6.62e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—POMC—lung cancer	3.94e-06	6.6e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APC—lung cancer	3.92e-06	6.57e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KIT—lung cancer	3.92e-06	6.57e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—lung cancer	3.92e-06	6.57e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.9e-06	6.54e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTP1—lung cancer	3.9e-06	6.52e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGF—lung cancer	3.88e-06	6.5e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NRAS—lung cancer	3.87e-06	6.49e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP2E1—lung cancer	3.87e-06	6.48e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CREBBP—lung cancer	3.84e-06	6.43e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NQO1—lung cancer	3.82e-06	6.4e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CAT—lung cancer	3.79e-06	6.35e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.77e-06	6.31e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.74e-06	6.27e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.71e-06	6.21e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK3—lung cancer	3.71e-06	6.21e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—STK11—lung cancer	3.69e-06	6.18e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—BRAF—lung cancer	3.69e-06	6.18e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCB1—lung cancer	3.69e-06	6.18e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CA—lung cancer	3.68e-06	6.16e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6R—lung cancer	3.64e-06	6.1e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CD—lung cancer	3.64e-06	6.09e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CREBBP—lung cancer	3.64e-06	6.09e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TYMS—lung cancer	3.62e-06	6.07e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—APOA1—lung cancer	3.6e-06	6.03e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALB—lung cancer	3.59e-06	6.02e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTM1—lung cancer	3.58e-06	6e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAP2K1—lung cancer	3.47e-06	5.81e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CD—lung cancer	3.45e-06	5.78e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—STK11—lung cancer	3.45e-06	5.77e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.45e-06	5.77e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTP1—lung cancer	3.41e-06	5.72e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP1A1—lung cancer	3.39e-06	5.68e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ERCC2—lung cancer	3.37e-06	5.64e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—KRAS—lung cancer	3.33e-06	5.58e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CAT—lung cancer	3.32e-06	5.56e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CG—lung cancer	3.29e-06	5.5e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.23e-06	5.42e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTP1—lung cancer	3.19e-06	5.34e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TYMS—lung cancer	3.17e-06	5.31e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CB—lung cancer	3.17e-06	5.31e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—lung cancer	3.14e-06	5.26e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTM1—lung cancer	3.14e-06	5.25e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—POMC—lung cancer	3.13e-06	5.24e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CAT—lung cancer	3.1e-06	5.2e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MDM2—lung cancer	3.09e-06	5.17e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.08e-06	5.17e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RAF1—lung cancer	3.08e-06	5.16e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CA—lung cancer	3.06e-06	5.13e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CREBBP—lung cancer	3.05e-06	5.1e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—lung cancer	3.05e-06	5.1e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCB1—lung cancer	3.02e-06	5.06e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—AKT1—lung cancer	3.01e-06	5.04e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CB—lung cancer	3.01e-06	5.03e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTOR—lung cancer	3.01e-06	5.03e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD4—lung cancer	3e-06	5.03e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP1A1—lung cancer	2.97e-06	4.98e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TYMS—lung cancer	2.96e-06	4.96e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—lung cancer	2.96e-06	4.96e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ERCC2—lung cancer	2.95e-06	4.94e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTM1—lung cancer	2.93e-06	4.91e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOA1—lung cancer	2.91e-06	4.88e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CD—lung cancer	2.89e-06	4.84e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALB—lung cancer	2.85e-06	4.78e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—HRAS—lung cancer	2.83e-06	4.75e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.79e-06	4.67e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP1A1—lung cancer	2.78e-06	4.65e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ERCC2—lung cancer	2.75e-06	4.61e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTEN—lung cancer	2.74e-06	4.59e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CG—lung cancer	2.66e-06	4.45e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—EP300—lung cancer	2.61e-06	4.38e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1A—lung cancer	2.6e-06	4.36e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PTEN—lung cancer	2.6e-06	4.35e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOA1—lung cancer	2.55e-06	4.27e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—POMC—lung cancer	2.53e-06	4.24e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CB—lung cancer	2.52e-06	4.22e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—AKT1—lung cancer	2.5e-06	4.19e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EP300—lung cancer	2.48e-06	4.15e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CREBBP—lung cancer	2.46e-06	4.13e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SRC—lung cancer	2.41e-06	4.03e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOA1—lung cancer	2.38e-06	3.99e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CD—lung cancer	2.34e-06	3.91e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CG—lung cancer	2.33e-06	3.9e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—lung cancer	2.32e-06	3.89e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NRAS—lung cancer	2.32e-06	3.88e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.28e-06	3.82e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK3—lung cancer	2.22e-06	3.72e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—POMC—lung cancer	2.22e-06	3.71e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CG—lung cancer	2.18e-06	3.64e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTEN—lung cancer	2.18e-06	3.64e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CREBBP—lung cancer	2.16e-06	3.62e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—lung cancer	2.16e-06	3.62e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—lung cancer	2.11e-06	3.54e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—EP300—lung cancer	2.07e-06	3.47e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—POMC—lung cancer	2.07e-06	3.47e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CD—lung cancer	2.05e-06	3.43e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CB—lung cancer	2.04e-06	3.41e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALB—lung cancer	2.02e-06	3.39e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—lung cancer	2.02e-06	3.38e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CREBBP—lung cancer	2.02e-06	3.38e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KRAS—lung cancer	1.99e-06	3.34e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CA—lung cancer	1.93e-06	3.24e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CD—lung cancer	1.91e-06	3.2e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALB—lung cancer	1.89e-06	3.16e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CA—lung cancer	1.83e-06	3.07e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CB—lung cancer	1.78e-06	2.99e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—lung cancer	1.77e-06	2.96e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTEN—lung cancer	1.76e-06	2.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HRAS—lung cancer	1.7e-06	2.84e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—EP300—lung cancer	1.68e-06	2.81e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CB—lung cancer	1.67e-06	2.79e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—lung cancer	1.65e-06	2.77e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—lung cancer	1.62e-06	2.72e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AKT1—lung cancer	1.58e-06	2.65e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTEN—lung cancer	1.54e-06	2.58e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CA—lung cancer	1.53e-06	2.57e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT1—lung cancer	1.5e-06	2.51e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—EP300—lung cancer	1.47e-06	2.46e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTEN—lung cancer	1.44e-06	2.41e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—EP300—lung cancer	1.37e-06	2.3e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AKT1—lung cancer	1.25e-06	2.1e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CA—lung cancer	1.24e-06	2.08e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CA—lung cancer	1.09e-06	1.82e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CA—lung cancer	1.02e-06	1.7e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AKT1—lung cancer	1.01e-06	1.7e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AKT1—lung cancer	8.89e-07	1.49e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AKT1—lung cancer	8.3e-07	1.39e-05	CbGpPWpGaD
